Ensysce Biosciences Correlations
ENSC Stock | USD 3.45 0.11 3.09% |
The current 90-days correlation between Ensysce Biosciences and Sonnet Biotherapeutics Holdings is 0.1 (i.e., Average diversification). The correlation of Ensysce Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Ensysce Biosciences Correlation With Market
Modest diversification
The correlation between Ensysce Biosciences and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ensysce Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Ensysce |
Moving together with Ensysce Stock
0.68 | CDIOW | Cardio Diagnostics | PairCorr |
0.67 | ELVN | Enliven Therapeutics | PairCorr |
0.75 | SCLX | Scilex Holding | PairCorr |
0.89 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
0.63 | CDIO | Cardio Diagnostics | PairCorr |
0.76 | CMND | Clearmind Medicine Common | PairCorr |
0.7 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.65 | CAT | Caterpillar | PairCorr |
0.63 | DIS | Walt Disney | PairCorr |
0.77 | MSFT | Microsoft | PairCorr |
Moving against Ensysce Stock
0.83 | WM | Waste Management | PairCorr |
0.82 | LUCD | Lucid Diagnostics | PairCorr |
0.63 | GE | GE Aerospace | PairCorr |
0.5 | PG | Procter Gamble | PairCorr |
0.44 | PLX | Protalix Biotherapeutics | PairCorr |
0.86 | JNJ | Johnson Johnson | PairCorr |
0.84 | T | ATT Inc Earnings Call Tomorrow | PairCorr |
0.71 | IBM | International Business | PairCorr |
0.7 | XOM | Exxon Mobil Corp | PairCorr |
0.7 | CVX | Chevron Corp | PairCorr |
0.64 | MMM | 3M Company | PairCorr |
0.56 | INTC | Intel | PairCorr |
0.47 | CSCO | Cisco Systems | PairCorr |
0.36 | DD | Dupont De Nemours | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ensysce Stock performing well and Ensysce Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ensysce Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ZURA | 4.61 | (0.40) | 0.00 | (0.23) | 0.00 | 9.79 | 29.06 | |||
PHIO | 11.03 | 2.00 | 0.17 | 0.42 | 9.59 | 9.40 | 336.29 | |||
SONN | 3.41 | (0.21) | 0.00 | (0.31) | 0.00 | 8.57 | 44.37 | |||
ATNF | 4.42 | (0.41) | 0.00 | (0.38) | 0.00 | 7.62 | 79.11 | |||
CDIO | 6.51 | (0.90) | 0.00 | (0.31) | 0.00 | 13.33 | 48.64 | |||
VRAX | 6.22 | (0.09) | 0.01 | 0.00 | 6.83 | 16.67 | 59.66 | |||
BWV | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
REVB | 5.58 | (0.68) | 0.00 | (1.73) | 0.00 | 11.78 | 66.25 | |||
HILS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
KPRX | 3.02 | 0.11 | 0.03 | 0.07 | 3.54 | 7.46 | 21.16 |
Ensysce Biosciences Corporate Management
MSE MBA | Chief Officer | Profile | |
Geoffrey Birkett | Chief Officer | Profile | |
Jeffrey Millard | Chief Officer | Profile | |
Linda Pestano | Chief Officer | Profile |